See also this year's filing and all EDGAR filings for this company.
PDF Report 0001053369_2023_ELITE_PHARMACEUTICALS_INC_NV.pdf
Logs
Graph
Absolute values for 0001053369, ELITE PHARMACEUTICALS INC NV
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 18,861,389 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 6,634,035 |
| 2 | PropertyPlantAndEquipmentNet | 5,952,992 |
| 3 | remainder_Assets | 3,700,482 |
| 4 | LiabilitiesCurrent | 6,694,241 |
| 5 | LiabilitiesNoncurrent | 3,232,630 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 17,466,763 |
| 8 | SellingGeneralAndAdministrativeExpense | 4,464,003 |
| 9 | ResearchAndDevelopmentExpense | 4,051,349 |
| 10 | remainder_Expenses | -527,145 |
| 11 | remainder_Revenues | 32,262,117 |
| 12 | remainder_NetIncome | 2,091,098 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 35,148,898 |
| 1 | Liabilities | 9,926,871 |
| 2 | Expenses | 25,454,970 |
| 3 | Revenues | 32,262,117 |
| 4 | StockholdersEquity | 25,222,027 |
| 5 | NetIncome | 8,898,245 |
| 6 | ComprehensiveNetIncome | 8,898,245 |
| 7 | BaseVar | 52,441,977 |
| 8 | EconomicCapitalRatio | 2.32 |
Edgar->Model Mapping
Feature Distribution
Change over Time
